PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Yu, Zhenming ^a   Zhu, Yongqing ^a   Chen Plotkin, Alice S ^c   Clay Falcone, Dana ^c   McCluskey, Leo ^c   Elman, Lauren ^c   Kalb, Robert G ^c,d   Trojanowski, John Q ^c   Lee, Virginia M Y ^c   van Deerlin, Vivianna M ^c   Gitler, Aaron D ^c   Bonini, Nancy M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 2; CYSTEINE PROTEINASE; POLYGLUTAMINE; UNCLASSIFIED DRUG; NERVE PROTEIN; PEPTIDE; SCA2 PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CAG REPEAT; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; EXON; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; NEUROPATHOLOGY; ONSET AGE; SINGLE NUCLEOTIDE POLYMORPHISM; TRINUCLEOTIDE REPEAT; ADULT; AGED; ALLELE; AMINO ACID SEQUENCE; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ADULT; AGE OF ONSET; AGED; ALLELES; AMYOTROPHIC LATERAL SCLEROSIS; BASE SEQUENCE; CASE-CONTROL STUDIES; CODON; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; PEPTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; REPETITIVE SEQUENCES, AMINO ACID; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 79953200132     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017951     Document Type: Article

References (62)

1. Cleveland DW, Rothstein JD, (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2: 806-819.
2. Chen-Plotkin AS, Lee VM, Trojanowski JQ, (2010) TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol 6: 211-220.
3. Pasinelli P, Brown RH, (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7: 710-723.
4. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62.
5. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130-133.
6. Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, et al. (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63: 535-538.
7. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, et al. (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40: 572-574.
8. Kuhnlein P, Sperfeld AD, Vanmassenhove B, Van Deerlin V, Lee VM, et al. (2008) Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. Arch Neurol 65: 1185-1189.
9. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, et al. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319: 1668-1672.
10. Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, et al. (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 14: 269-276.
11. Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, et al. (1996) Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 14: 277-284.
12. Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, et al. (1996) Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet 14: 285-291.
13. Gusella JF, MacDonald ME, (2000) Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci 1: 109-115.
14. Cancel G, Durr A, Didierjean O, Imbert G, Burk K, et al. (1997) Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet 6: 709-715.
15. Geschwind DH, Perlman S, Figueroa CP, Treiman LJ, Pulst SM, (1997) The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet 60: 842-850.
16. Lorenzetti D, Bohlega S, Zoghbi HY, (1997) The expansion of the CAG repeat in ataxin-2 is a frequent cause of autosomal dominant spinocerebellar ataxia. Neurology 49: 1009-1013.
17. Giunti P, Sabbadini G, Sweeney MG, Davis MB, Veneziano L, et al. (1998) The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates. Brain 121 (Pt 3): 459-467.
18. Saleem Q, Choudhry S, Mukerji M, Bashyam L, Padma MV, et al. (2000) Molecular analysis of autosomal dominant hereditary ataxias in the Indian population: high frequency of SCA2 and evidence for a common founder mutation. Hum Genet 106: 179-187.
19. Choudhry S, Mukerji M, Srivastava AK, Jain S, Brahmachari SK, (2001) CAG repeat instability at SCA2 locus: anchoring CAA interruptions and linked single nucleotide polymorphisms. Hum Mol Genet 10: 2437-2446.
20. Costanzi-Porrini S, Tessarolo D, Abbruzzese C, Liguori M, Ashizawa T, et al. (2000) An interrupted 34-CAG repeat SCA-2 allele in patients with sporadic spinocerebellar ataxia. Neurology 54: 491-493.
21. Kim JM, Hong S, Kim GP, Choi YJ, Kim YK, et al. (2007) Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism. Arch Neurol 64: 1510-1518.
22. Gwinn-Hardy K, Chen JY, Liu HC, Liu TY, Boss M, et al. (2000) Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology 55: 800-805.
23. Shan DE, Soong BW, Sun CM, Lee SJ, Liao KK, et al. (2001) Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive parkinsonism. Ann Neurol 50: 812-815.
24. Furtado S, Farrer M, Tsuboi Y, Klimek ML, de la Fuente-Fernandez R, et al. (2002) SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings. Neurology 59: 1625-1627.
25. Lu CS, Wu Chou YH, Kuo PC, Chang HC, Weng YH, (2004) The parkinsonian phenotype of spinocerebellar ataxia type 2. Arch Neurol 61: 35-38.
26. Ragothaman M, Sarangmath N, Chaudhary S, Khare V, Mittal U, et al. (2004) Complex phenotypes in an Indian family with homozygous SCA2 mutations. Ann Neurol 55: 130-133.
27. Charles P, Camuzat A, Benammar N, Sellal F, Destee A, et al. (2007) Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism? Neurology 69: 1970-1975.
28. Modoni A, Contarino MF, Bentivoglio AR, Tabolacci E, Santoro M, et al. (2007) Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patients. Mov Disord 22: 324-327.
29. Socal MP, Emmel VE, Rieder CR, Hilbig A, Saraiva-Pereira ML, et al. (2009) Intrafamilial variability of Parkinson phenotype in SCAs: novel cases due to SCA2 and SCA3 expansions. Parkinsonism Relat Disord 15: 374-378.
30. Wang JL, Xiao B, Cui XX, Guo JF, Lei LF, et al. (2009) Analysis of SCA2 and SCA3/MJD repeats in Parkinson's disease in mainland China: genetic, clinical, and positron emission tomography findings. Mov Disord 24: 2007-2011.
31. Elden A, Kim H-J, Hart M, Chen-Plotkin A, Johnson B, et al. (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased susceptibility to amyotrophic lateral sclerosis. Nature 466: 1069-1075.
32. Infante J, Berciano J, Volpini V, Corral J, Polo JM, et al. (2004) Spinocerebellar ataxia type 2 with Levodopa-responsive parkinsonism culminating in motor neuron disease. Mov Disord 19: 848-852.
33. Nanetti L, Fancellu R, Tomasello C, Gellera C, Pareyson D, et al. (2009) Rare association of motor neuron disease and spinocerebellar ataxia type 2 (SCA2): a new case and review of the literature. J Neurol 256: 1926-1928.
34. Neff MM, Neff JD, Chory J, Pepper AE, (1998) dCAPS, a simple technique for the genetic analysis of single nucleotide polymorphisms: experimental applications in Arabidopsis thaliana genetics. Plant J 14: 387-392.
35. Riess O, Laccone FA, Gispert S, Schols L, Zuhlke C, et al. (1997) SCA2 trinucleotide expansion in German SCA patients. Neurogenetics 1: 59-64.
36. Ramos EM, Martins S, Alonso I, Emmel VE, Saraiva-Pereira ML, et al. (2009) Common origin of pure and interrupted repeat expansions in spinocerebellar ataxia type 2 (SCA2). Am J Med Genet B Neuropsychiatr Genet 153B: 524-531.
37. Orr HT, Zoghbi HY, (2007) Trinucleotide repeat disorders. Annu Rev Neurosci 30: 575-621.
38. Lee T, Li YR, Ingre C, Weber M, Grehl T, et al. (2011) Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Hum Mol Genet.
39. Hoche F, Baliko L, den Dunnen W, Steinecker K, Bartos L, et al. (2010) Spinocerebellar Ataxia Type 2 (SCA2): Identification of Early Brain Degeneration in One Monozygous Twin in the Initial Disease Stage. Cerebellum.
40. Ishida C, Komai K, Yonezawa K, Sakajiri KI, Nitta E, et al. (2010) An autopsy case of an aged patient with spinocerebellar ataxia type 2. Neuropathology.
41. Lastres-Becker I, Rub U, Auburger G, (2008) Spinocerebellar ataxia 2 (SCA2). Cerebellum 7: 115-124.
42. Li LB, Yu Z, Teng X, Bonini NM, (2008) RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature 453: 1107-1111.
43. Hsu RJ, Hsiao KM, Lin MJ, Li CY, Wang LC, et al. (2011) Long Tract of Untranslated CAG Repeats Is Deleterious in Transgenic Mice. PLoS One 6: e16417.
44. Wang LC, Chen KY, Pan H, Wu CC, Chen PH, et al. (2010) Muscleblind participates in RNA toxicity of expanded CAG and CUG repeats in Caenorhabditis elegans. Cell Mol Life Sci DOI:10.1007/s00018-010-0522-4.
45. Matsuyama Z, Izumi Y, Kameyama M, Kawakami H, Nakamura S, (1999) The effect of CAT trinucleotide interruptions on the age at onset of spinocerebellar ataxia type 1 (SCA1). J Med Genet 36: 546-548.
46. Nakamura K, Jeong SY, Uchihara T, Anno M, Nagashima K, et al. (2001) SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 10: 1441-1448.
47. Zuhlke C, Hellenbroich Y, Dalski A, Kononowa N, Hagenah J, et al. (2001) Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Hum Genet 9: 160-164.
48. Koide R, Kobayashi S, Shimohata T, Ikeuchi T, Maruyama M, et al. (1999) A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum Mol Genet 8: 2047-2053.
49. van Roon-Mom WM, Reid SJ, Faull RL, Snell RG, (2005) TATA-binding protein in neurodegenerative disease. Neuroscience 133: 863-872.
50. Cronin S, Berger S, Ding J, Schymick JC, Washecka N, et al. (2008) A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum Mol Genet 17: 768-774.
51. Cronin S, Tomik B, Bradley DG, Slowik A, Hardiman O, (2009) Screening for replication of genome-wide SNP associations in sporadic ALS. Eur J Hum Genet 17: 213-218.
52. Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, et al. (2007) Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med 357: 775-788.
53. van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, et al. (2009) Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet 41: 1083-1087.
54. Cronin S, Blauw HM, Veldink JH, van Es MA, Ophoff RA, et al. (2008) Analysis of genome-wide copy number variation in Irish and Dutch ALS populations. Hum Mol Genet 17: 3392-3398.
55. Pearson CE, Eichler EE, Lorenzetti D, Kramer SF, Zoghbi HY, et al. (1998) Interruptions in the triplet repeats of SCA1 and FRAXA reduce the propensity and complexity of slipped strand DNA (S-DNA) formation. Biochemistry 37: 2701-2708.
56. Gao R, Matsuura T, Coolbaugh M, Zuhlke C, Nakamura K, et al. (2008) Instability of expanded CAG/CAA repeats in spinocerebellar ataxia type 17. Eur J Hum Genet 16: 215-222.
57. Pearson CE, Nichol Edamura K, Cleary JD, (2005) Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 6: 729-742.
58. Sobczak K, Krzyzosiak WJ, (2005) CAG repeats containing CAA interruptions form branched hairpin structures in spinocerebellar ataxia type 2 transcripts. J Biol Chem 280: 3898-3910.
59. Sofola OA, Jin P, Qin Y, Duan R, Liu H, et al. (2007) RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron 55: 565-571.
60. Jin P, Duan R, Qurashi A, Qin Y, Tian D, et al. (2007) Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron 55: 556-564.
61. Ranum LP, Cooper TA, (2006) RNA-mediated neuromuscular disorders. Annu Rev Neurosci 29: 259-277.
62. Lagier-Tourenne C, Cleveland DW, (2009) Rethinking ALS: the FUS about TDP-43. Cell 136: 1001-1004.